Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 25544 | $21,802,239,790 |
Sells | 81296 | $198,142,637,334 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
06 Jul 2023 17:31 | ABNB | Airbnb Inc | BALOGH ARISTOTLE N | Chief Technology Officer | 03 Jul 2023 | Sale | 14,756 | 132.5838 | 1,956,407 | D |
06 Jul 2023 17:31 | ABNB | Airbnb Inc | BALOGH ARISTOTLE N | Chief Technology Officer | 03 Jul 2023 | Sale | 2,750 | 129.28 | 355,520 | D |
06 Jul 2023 17:24 | ABNB | Airbnb Inc | CHESKY BRIAN | CEO and Chairman, 10% | 03 Jul 2023 | Sale | 1,400 | 133.7793 | 187,291 | D |
06 Jul 2023 17:24 | ABNB | Airbnb Inc | CHESKY BRIAN | CEO and Chairman, 10% | 03 Jul 2023 | Sale | 15,962 | 132.8622 | 2,120,746 | D |
06 Jul 2023 17:24 | ABNB | Airbnb Inc | CHESKY BRIAN | CEO and Chairman, 10% | 03 Jul 2023 | Sale | 9,247 | 132.2372 | 1,222,797 | D |
06 Jul 2023 17:24 | ABNB | Airbnb Inc | CHESKY BRIAN | CEO and Chairman, 10% | 03 Jul 2023 | Sale | 2,991 | 130.8521 | 391,379 | D |
06 Jul 2023 17:24 | ABNB | Airbnb Inc | CHESKY BRIAN | CEO and Chairman, 10% | 03 Jul 2023 | Sale | 400 | 130.025 | 52,010 | D |
06 Jul 2023 17:15 | ABNB | Airbnb Inc | STEPHENSON DAVE | Chief Financial Officer | 03 Jul 2023 | Sale | 4,919 | 129.28 | 635,928 | D |
29 Jun 2023 16:05 | ABNB | Airbnb Inc | GEBBIA JOSEPH | Director , 10% | 27 Jun 2023 | Sale | 1,404 | 126.0438 | 176,965 | I |
29 Jun 2023 16:05 | ABNB | Airbnb Inc | GEBBIA JOSEPH | Director , 10% | 27 Jun 2023 | Sale | 212,322 | 125.3342 | 26,611,208 | I |
29 Jun 2023 16:05 | ABNB | Airbnb Inc | GEBBIA JOSEPH | Director , 10% | 27 Jun 2023 | Sale | 260,597 | 124.2155 | 32,370,187 | I |
29 Jun 2023 16:05 | ABNB | Airbnb Inc | GEBBIA JOSEPH | Director , 10% | 27 Jun 2023 | Sale | 42,344 | 123.815 | 5,242,822 | I |
28 Jun 2023 17:18 | ABNB | Airbnb Inc | BALOGH ARISTOTLE N | Chief Technology Officer | 27 Jun 2023 | Sale | 2,750 | 124.41 | 342,128 | D |
28 Jun 2023 17:18 | ABNB | Airbnb Inc | BALOGH ARISTOTLE N | Chief Technology Officer | 26 Jun 2023 | Sale | 2,750 | 123 | 338,250 | D |
19 Jan 2024 19:05 | ABOS | Acumen Pharmaceuticals Inc | SIEMERS ERIC | Chief Medical Officer | 18 Jan 2024 | Sale | 3,124 | 3.7144 | 11,604 | D |
19 Jan 2024 19:05 | ABOS | Acumen Pharmaceuticals Inc | ZUGA MATT | CFO & Chief Business Officer | 18 Jan 2024 | Sale | 4,242 | 3.705 | 15,717 | D |
19 Jan 2024 19:06 | ABOS | Acumen Pharmaceuticals Inc | MEISNER DEREK M | Chief Legal Officer & Corp Sec | 19 Jan 2024 | Sale | 8,933 | 3.4757 | 31,048 | D |
19 Jan 2024 19:07 | ABOS | Acumen Pharmaceuticals Inc | OCONNELL DANIEL JOSEPH | President and CEO | 19 Jan 2024 | Sale | 15,200 | 3.4706 | 52,753 | D |
19 Jan 2024 19:04 | ABOS | Acumen Pharmaceuticals Inc | BARTON RUSSELL | Chief Operating Officer | 18 Jan 2024 | Sale | 2,833 | 3.7258 | 10,555 | D |
18 Aug 2023 18:31 | ABOS | Acumen Pharmaceuticals Inc | IVES JEFFREY L. | Director | 17 Aug 2023 | Sale | 2,800 | 6.66 | 18,648 | D |
18 Aug 2023 18:31 | ABOS | Acumen Pharmaceuticals Inc | IVES JEFFREY L. | Director | 17 Aug 2023 | Sale | 39,149 | 6.48 | 253,686 | D |
25 Jul 2023 16:30 | ABOS | Acumen Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 21 Jul 2023 | Purchase | 5,161,290 | 7.75 | 39,999,998 | I |
24 Jan 2024 12:57 | ABQQ | AB INTERNATIONAL GROUP Corp | DENG CHIYUAN | Chief Executive Officer, 10% | 24 Jan 2024 | Purchase | 23,000,000 | 0.002 | 46,000 | D |
20 Dec 2023 12:12 | ABQQ | AB INTERNATIONAL GROUP Corp | DENG CHIYUAN | Chief Executive Officer, 10% | 20 Dec 2023 | Purchase | 7,540,000 | 0.002 | 15,080 | D |
15 Dec 2023 11:33 | ABQQ | AB INTERNATIONAL GROUP Corp | DENG CHIYUAN | Chief Executive Officer, 10% | 14 Dec 2023 | Purchase | 43,000,000 | 0.0016 | 68,800 | D |
12 Dec 2023 11:35 | ABQQ | AB INTERNATIONAL GROUP Corp | DENG CHIYUAN | Chief Executive Officer, 10% | 11 Dec 2023 | Purchase | 151,000,000 | 0.001 | 151,000 | D |
18 Oct 2023 13:57 | ABQQ | AB INTERNATIONAL GROUP Corp | DENG CHIYUAN | Chief Executive Officer, 10% | 05 Oct 2023 | Purchase | 225,000,000 | 0.0002 | 45,000 | D |
29 Nov 2023 16:40 | ABR | ARBOR REALTY TRUST INC | ELENIO PAUL | Chief Financial Officer | 28 Nov 2023 | Purchase | 2,500 | 11.9 | 29,750 | D |
29 Nov 2023 16:40 | ABR | ARBOR REALTY TRUST INC | ELENIO PAUL | Chief Financial Officer | 27 Nov 2023 | Purchase | 2,500 | 12.03 | 30,075 | D |
29 Nov 2023 16:39 | ABR | ARBOR REALTY TRUST INC | KAUFMAN IVAN | COB, CEO and President | 29 Nov 2023 | Purchase | 10,000 | 12.05 | 120,500 | D |
29 Nov 2023 16:39 | ABR | ARBOR REALTY TRUST INC | KAUFMAN IVAN | COB, CEO and President | 28 Nov 2023 | Purchase | 10,000 | 11.86 | 118,600 | D |
29 Nov 2023 16:39 | ABR | ARBOR REALTY TRUST INC | KAUFMAN IVAN | COB, CEO and President | 27 Nov 2023 | Purchase | 20,000 | 12.04 | 240,800 | D |
24 Nov 2023 16:11 | ABR | ARBOR REALTY TRUST INC | KAUFMAN IVAN | COB, CEO and President | 24 Nov 2023 | Purchase | 20,000 | 12.15 | 243,000 | D |
24 Nov 2023 16:11 | ABR | ARBOR REALTY TRUST INC | KAUFMAN IVAN | COB, CEO and President | 21 Nov 2023 | Purchase | 15,000 | 12.23 | 183,450 | D |
24 Nov 2023 15:57 | ABR | ARBOR REALTY TRUST INC | ELENIO PAUL | Chief Financial Officer | 21 Nov 2023 | Purchase | 2,500 | 12.2 | 30,500 | D |
20 Nov 2023 16:37 | ABR | ARBOR REALTY TRUST INC | ELENIO PAUL | Chief Financial Officer | 16 Nov 2023 | Purchase | 7,500 | 12.37 | 92,775 | D |
09 Nov 2023 16:15 | ABR | ARBOR REALTY TRUST INC | GREEN WILLIAM C | Director | 08 Nov 2023 | Purchase | 4,919 | 13 | 63,947 | D |
08 Nov 2023 16:15 | ABR | ARBOR REALTY TRUST INC | KAUFMAN IVAN | COB, CEO and President | 06 Nov 2023 | Purchase | 10,000 | 12.47 | 124,700 | D |
01 Nov 2023 16:30 | ABR | ARBOR REALTY TRUST INC Preferred |
NATALONE JOHN | EVP, Treasury and Servicing | 30 Oct 2023 | Sale | 80,161 | 12.47 | 999,608 | I |
01 Nov 2023 16:34 | ABR | ARBOR REALTY TRUST INC Preferred |
MARTELLO JOSEPH | Director | 30 Oct 2023 | Sale | 80,161 | 12.47 | 999,608 | I |
01 Nov 2023 16:28 | ABR | ARBOR REALTY TRUST INC Preferred |
KAUFMAN IVAN | COB, CEO and President | 30 Oct 2023 | Purchase | 80,161 | 12.47 | 999,608 | D |
12 Jun 2024 16:41 | ABR | ARBOR REALTY TRUST INC | FRIEDMAN DAVID ERWIN | CCO & Head of Non-Agcy Prod | 11 Jun 2024 | Purchase | 4,775 | 13.37 | 63,842 | D |
12 Jun 2024 16:41 | ABR | ARBOR REALTY TRUST INC | FRIEDMAN DAVID ERWIN | CCO & Head of Non-Agcy Prod | 11 Jun 2024 | Purchase | 100 | 13.415 | 1,342 | D |
12 Jun 2024 16:41 | ABR | ARBOR REALTY TRUST INC | FRIEDMAN DAVID ERWIN | CCO & Head of Non-Agcy Prod | 11 Jun 2024 | Purchase | 200 | 13.36 | 2,672 | D |
12 Jun 2024 16:41 | ABR | ARBOR REALTY TRUST INC | FRIEDMAN DAVID ERWIN | CCO & Head of Non-Agcy Prod | 11 Jun 2024 | Purchase | 200 | 13.355 | 2,671 | D |
20 Mar 2024 16:31 | ABR | ARBOR REALTY TRUST INC | GREEN WILLIAM C | Director | 18 Mar 2024 | Purchase | 100 | 12.935 | 1,294 | D |
20 Mar 2024 16:31 | ABR | ARBOR REALTY TRUST INC | GREEN WILLIAM C | Director | 18 Mar 2024 | Purchase | 1,630 | 12.93 | 21,076 | D |
20 Mar 2024 16:31 | ABR | ARBOR REALTY TRUST INC | GREEN WILLIAM C | Director | 18 Mar 2024 | Purchase | 3,091 | 12.92 | 39,936 | D |
20 Mar 2024 16:31 | ABR | ARBOR REALTY TRUST INC | GREEN WILLIAM C | Director | 18 Mar 2024 | Purchase | 5,388 | 12.94 | 69,721 | D |
05 Mar 2024 21:30 | ABSI | Absci Corp | REDMILE GROUP, LLC | Director | 01 Mar 2024 | Purchase | 222,222 | 4.5 | 999,999 | I |
14 Jun 2024 16:40 | ABSI | Absci Corp | JONASSON ZACHARIAH | CFO / CBO | 13 Jun 2024 | Sale | 19,859 | 4.9797 | 98,892 | D |
28 May 2024 13:56 | ABSI | Absci Corp | PHOENIX VENTURE PARTNERS II LP | 10% | 22 May 2024 | Sale | 3,100,000 | 4.4 | 13,640,000 | D |
04 Mar 2024 19:18 | ABT | ABBOTT LABORATORIES | SALVADORI DANIEL GESUA SIVE | EXECUTIVE VICE PRESIDENT | 01 Mar 2024 | Sale | 963 | 118.5 | 114,116 | D |
04 Mar 2024 19:09 | ABT | ABBOTT LABORATORIES | MORELAND MARY K | EXECUTIVE VICE PRESIDENT | 01 Mar 2024 | Sale | 676 | 118.5 | 80,106 | D |
04 Mar 2024 19:14 | ABT | ABBOTT LABORATORIES | MORRONE LOUIS H. | EXECUTIVE VICE PRESIDENT | 01 Mar 2024 | Sale | 801 | 118.5 | 94,918 | D |
04 Mar 2024 19:05 | ABT | ABBOTT LABORATORIES | MCCOY JOHN A. JR. | VICE PRESIDENT | 01 Mar 2024 | Sale | 472 | 118.5 | 55,932 | D |
04 Mar 2024 18:50 | ABT | ABBOTT LABORATORIES | EARNHARDT LISA D | EXECUTIVE VICE PRESIDENT | 01 Mar 2024 | Sale | 694 | 118.5 | 82,239 | D |
04 Mar 2024 18:39 | ABT | ABBOTT LABORATORIES | ALLEN HUBERT L | EXECUTIVE VICE PRESIDENT | 01 Mar 2024 | Sale | 853 | 118.5 | 101,080 | D |
27 Feb 2024 18:13 | ABT | ABBOTT LABORATORIES | WAINER ANDREA F | EXECUTIVE VICE PRESIDENT | 23 Feb 2024 | Sale | 12,500 | 120 | 1,500,000 | D |
31 Jan 2024 17:30 | ABT | ABBOTT LABORATORIES | WAINER ANDREA F | EXECUTIVE VICE PRESIDENT | 29 Jan 2024 | Sale | 17,500 | 112.5 | 1,968,750 | D |
31 Jan 2024 17:30 | ABT | ABBOTT LABORATORIES | WAINER ANDREA F | EXECUTIVE VICE PRESIDENT | 29 Jan 2024 | Sale | 25,000 | 112.5 | 2,812,500 | D |
18 Dec 2023 17:36 | ABT | ABBOTT LABORATORIES | WAINER ANDREA F | EXECUTIVE VICE PRESIDENT | 14 Dec 2023 | Sale | 15,000 | 108 | 1,620,000 | D |
30 Oct 2023 16:58 | ABT | ABBOTT LABORATORIES | STARKS DANIEL J | Director | 26 Oct 2023 | Sale | 23,093 | 94.326 | 2,178,270 | D |
30 Oct 2023 16:58 | ABT | ABBOTT LABORATORIES | STARKS DANIEL J | Director | 26 Oct 2023 | Sale | 26,907 | 93.8141 | 2,524,256 | D |
14 May 2024 17:35 | ABT | ABBOTT LABORATORIES | FUNCK, JR. ROBERT E. | EXECUTIVE VICE PRESIDENT | 10 May 2024 | Sale | 10,097 | 104.5676 | 1,055,819 | D |
08 May 2024 17:00 | ABT | ABBOTT LABORATORIES | EARNHARDT LISA D | EXECUTIVE VICE PRESIDENT | 07 May 2024 | Sale | 22,852 | 106.2541 | 2,428,119 | D |
10 Aug 2023 18:31 | ABT | ABBOTT LABORATORIES | WAINER ANDREA F | EXECUTIVE VICE PRESIDENT | 08 Aug 2023 | Sale | 16 | 107.42 | 1,719 | D |
10 Aug 2023 18:31 | ABT | ABBOTT LABORATORIES | WAINER ANDREA F | EXECUTIVE VICE PRESIDENT | 08 Aug 2023 | Sale | 272 | 105.43 | 28,677 | D |
10 Aug 2023 18:31 | ABT | ABBOTT LABORATORIES | WAINER ANDREA F | EXECUTIVE VICE PRESIDENT | 08 Aug 2023 | Sale | 5,112 | 105 | 536,760 | D |
10 Aug 2023 18:31 | ABT | ABBOTT LABORATORIES | WAINER ANDREA F | EXECUTIVE VICE PRESIDENT | 08 Aug 2023 | Sale | 15 | 107.42 | 1,611 | D |
10 Aug 2023 18:31 | ABT | ABBOTT LABORATORIES | WAINER ANDREA F | EXECUTIVE VICE PRESIDENT | 08 Aug 2023 | Sale | 244 | 105.43 | 25,725 | D |
10 Aug 2023 18:31 | ABT | ABBOTT LABORATORIES | WAINER ANDREA F | EXECUTIVE VICE PRESIDENT | 08 Aug 2023 | Sale | 4,741 | 105 | 497,805 | D |
28 Jul 2023 17:10 | ABT | ABBOTT LABORATORIES | STARKS DANIEL J | Director | 27 Jul 2023 | Sale | 29,066 | 114.0054 | 3,313,681 | D |
28 Jul 2023 17:10 | ABT | ABBOTT LABORATORIES | STARKS DANIEL J | Director | 27 Jul 2023 | Sale | 20,934 | 113.4283 | 2,374,508 | D |
05 Feb 2024 19:54 | ABUS | Arbutus Biopharma Corp | HASTINGS DAVID C | Chief Financial Officer | 02 Feb 2024 | Sale | 9,593 | 2.3125 | 22,184 | D |
05 Feb 2024 19:55 | ABUS | Arbutus Biopharma Corp | SIMS KAREN | Chief Medical Officer | 02 Feb 2024 | Sale | 4,358 | 2.3125 | 10,078 | D |
05 Feb 2024 19:54 | ABUS | Arbutus Biopharma Corp | MCELHAUGH MICHAEL J. | Interim President & CEO | 02 Feb 2024 | Sale | 10,164 | 2.3125 | 23,504 | D |
05 Feb 2024 19:54 | ABUS | Arbutus Biopharma Corp | SOFIA MICHAEL J. | Chief Scientific Officer | 02 Feb 2024 | Sale | 9,982 | 2.3125 | 23,083 | D |
16 May 2024 17:06 | ACA | Arcosa Inc | COLLINS JESSE E. JR. | Group President | 15 May 2024 | Sale | 5,977 | 88.88 | 531,236 | D |
16 May 2024 17:06 | ACA | Arcosa Inc | COLLINS JESSE E. JR. | Group President | 15 May 2024 | Sale | 3,649 | 88.44 | 322,718 | D |
16 May 2024 17:07 | ACA | Arcosa Inc | COLE KERRY S | Group President | 15 May 2024 | Sale | 3,959 | 88.42 | 350,055 | D |
16 May 2024 17:07 | ACA | Arcosa Inc | COLE KERRY S | Group President | 15 May 2024 | Sale | 7,019 | 88.87 | 623,779 | D |
17 Aug 2023 17:41 | ACA | Arcosa Inc | CARRILLO ANTONIO | President & CEO | 17 Aug 2023 | Sale | 4,074 | 76.45 | 311,457 | D |
17 Aug 2023 17:41 | ACA | Arcosa Inc | CARRILLO ANTONIO | President & CEO | 17 Aug 2023 | Sale | 3,060 | 77.15 | 236,079 | D |
17 Aug 2023 17:41 | ACA | Arcosa Inc | CARRILLO ANTONIO | President & CEO | 17 Aug 2023 | Sale | 1,264 | 75.69 | 95,672 | D |
16 Aug 2023 18:16 | ACA | Arcosa Inc | CARRILLO ANTONIO | President & CEO | 16 Aug 2023 | Sale | 6,967 | 78.22 | 544,959 | D |
16 Aug 2023 18:16 | ACA | Arcosa Inc | CARRILLO ANTONIO | President & CEO | 16 Aug 2023 | Sale | 7,835 | 77.51 | 607,291 | D |
16 Aug 2023 18:16 | ACA | Arcosa Inc | CARRILLO ANTONIO | President & CEO | 16 Aug 2023 | Sale | 11,431 | 76.65 | 876,186 | D |
16 Aug 2023 18:16 | ACA | Arcosa Inc | CARRILLO ANTONIO | President & CEO | 15 Aug 2023 | Sale | 12,711 | 78.34 | 995,780 | D |
16 Aug 2023 18:16 | ACA | Arcosa Inc | CARRILLO ANTONIO | President & CEO | 15 Aug 2023 | Sale | 1,700 | 77.6 | 131,920 | D |
27 Feb 2024 18:10 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, HEAD OF COMMERCIAL | 26 Feb 2024 | Sale | 624 | 24.67 | 15,394 | D |
27 Feb 2024 18:13 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 26 Feb 2024 | Sale | 772 | 24.67 | 19,045 | D |
27 Feb 2024 18:07 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | PRINCIPAL ACCOUNTING OFFICER | 26 Feb 2024 | Sale | 474 | 24.67 | 11,694 | D |
27 Feb 2024 18:02 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 26 Feb 2024 | Sale | 5,577 | 24.67 | 137,585 | D |
09 Jan 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | DAVIS STEPHEN | CEO | 08 Jan 2024 | Sale | 3,732 | 29.96 | 111,811 | D |
09 Jan 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | TEEHAN BRENDAN | EVP, COO, Head of Commercial | 08 Jan 2024 | Sale | 731 | 29.96 | 21,901 | D |
09 Jan 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | KIM AUSTIN D. | EVP,General Counsel, Secretary | 08 Jan 2024 | Sale | 590 | 29.96 | 17,676 | D |
15 Dec 2023 19:37 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | Principal Accounting Officer | 15 Dec 2023 | Sale | 2,000 | 28.3 | 56,600 | D |
21 Nov 2023 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | KIHARA JAMES | Principal Accounting Officer | 20 Nov 2023 | Sale | 1,985 | 22.64 | 44,940 | D |
21 Nov 2023 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 20 Nov 2023 | Sale | 5,108 | 22.64 | 115,645 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)